ENHERTU — DAIICHI SANKYO, approved 2026-05-15 (BLA761139).
8,971 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.